B. Drakulić

发表

4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.

M. Vitorović-Todorović, I. Juranić, L. Mandić, 2010, Bioorganic & medicinal chemistry.

The 3D-QSAR study of 110 diverse, dual binding, acetylcholinesterase inhibitors based on alignment independent descriptors (GRIND-2). The effects of conformation on predictive power and interpretability of the models.

M. Vitorović-Todorović, I. Juranić, B. Drakulić, 2012, Journal of molecular graphics & modelling.

Solvatochromism of symmetrical 2,6-distyrylpyridines. An experimental and theoretical study.

A. Marinkovic, K. Radotić, D. Mutavdžić, 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

Role of complexes formation between drugs and penetration enhancers in transdermal delivery.

M. Zloh, I. Juranić, B. Drakulić, 2008, International journal of pharmaceutics.

Antiproliferative activity of aroylacrylic acids. Structure-activity study based on molecular interaction fields.

T. Stanojković, Z. Zizak, B. Drakulić, 2011, European journal of medicinal chemistry.

Aryldiketo Acids Have Antibacterial Activity Against MDR Staphylococcus aureus Strains: Structural Insights Based on Similarity and Molecular Interaction Fields

M. Zloh, S. Gibbons, Z. Zizak, 2009, ChemMedChem.

Antiproliferative and antibacterial activity of some glutarimide derivatives

I. Matić, Z. Zizak, B. Drakulić, 2016, Journal of enzyme inhibition and medicinal chemistry.

5-Aryl-1H-pyrazole-3-carboxylic acids as selective inhibitors of human carbonic anhydrases IX and XII.

C. Supuran, I. Juranić, B. Drakulić, 2015, Bioorganic & medicinal chemistry.

Acute Toxicity of Substituted 2‐(1H‐pyrazol‐1‐yl)acetanilides and Related Commercially Available Local Anesthetics Toward Mice. A GRIND/ALMOND‐Based 3‐D QSAR Study

B. Drakulić, M. Iovu, C. Zălaru, 2009 .

(E)-4-aryl-4-oxo-2-butenoic acid amides, chalcone-aroylacrylic acid chimeras: design, antiproliferative activity and inhibition of tubulin polymerization.

B. Kolundžija, E. Hamel, M. Vitorović-Todorović, 2013, European journal of medicinal chemistry.

Tautomerism of 4-phenyl-2,4-dioxobutanoic acid. Insights from pH ramping NMR study and quantum chemical calculations

M. Zloh, I. Juranić, B. Drakulić, 2018, Structural Chemistry.

Human Serum Albumin Binding of 2-((Carboxymethyl)sulfanyl)- 4-oxo-4-(4-tert-butylphenyl)butanoic Acid and its Mono-Me Ester

D. Petrović, I. Juranić, B. Drakulić, 2014 .

2-[(Carboxymethyl)sulfanyl]-4-oxo-4-arylbutanoic Acids Suppressed Survival of Neoplastic Human HeLa Cells: A QSAR Study

I. Juranić, B. Drakulić, Z. Juranić, 2005 .

Synthesis, structure and magnetic properties of the first copper(II) complex with an (E)-4-aryl-4-oxo-2-butenoato ligand

G. Bogdanović, I. Juranić, B. Drakulić, 2006 .

Reactivity of (E)-4-aryl-4-oxo-2-butenoic acid phenylamides with piperidine and benzylamine: kinetic and theoretical study

Đura Nakarada, M. Vitorović-Todorović, I. Juranić, 2014, Monatshefte für Chemie - Chemical Monthly.

2-[(Carboxymethyl)sulfanyl]-4-oxo-4-arylbutanoic acids selectively suppressed proliferation of neoplastic human HeLa cells. A SAR/QSAR study.

T. Stanojković, I. Juranić, B. Drakulić, 2005, Journal of medicinal chemistry.

SUBSTITUED (E)-BETA -(BENZOYL)ACRYLIC ACIDS SUPPRESSED SURVIVAL OF NEOPLASTIC HUMAN HELA CELLS

S. Radulović, T. Stanojković, I. Juranić, 1999 .

Effect of malondialdehyde on the ovalbumin structure and its interactions with T84 epithelial cells.

M. Gavrović-Jankulović, M. Atanasković-Marković, B. Drakulić, 2017, Biochimica et biophysica acta. General subjects.

Conformational mobility of active and E-64-inhibited actinidin.

M. Gavrović-Jankulović, B. Drakulić, Milica M. Grozdanovic, 2013, Biochimica et biophysica acta.

On the choice of optimal conformation in linear free-energy relationships. Reactivity of 2-((carboxymethyl)sulfanyl)-4-oxo-4-arylbutanoic acids with diphenyldiazomethane

I. Juranić, B. Drakulić, A. Marinković, 2012 .

Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.

M. Vitorović-Todorović, I. Juranić, L. Mandić, 2014, European journal of medicinal chemistry.

An alignment independent 3D QSAR study of the antiproliferative activity of 1,2,4,5-tetraoxanes.

T. Stanojković, I. Juranić, B. Drakulić, 2010, European journal of medicinal chemistry.

Reactivity of (E)-4-aryl-4-oxo-2-butenoic acid arylamides toward 2-mercaptoethanol. A LFER study

M. Vitorović-Todorović, I. Juranić, B. Drakulić, 2013, Monatshefte für Chemie - Chemical Monthly.

Design, synthesis and biological evaluation of novel aryldiketo acids with enhanced antibacterial activity against multidrug resistant bacterial strains.

M. Zloh, S. Gibbons, P. Stapleton, 2018, European journal of medicinal chemistry.

Modulation of the specific immune response in Balb/c mice by intranasal application of recombinant H1D2 chimera

M. Gavrović-Jankulović, M. Atanasković-Marković, B. Drakulić, 2017 .

Linear free energy relationships of half-wave reduction potentials of (E)-4-aryl-4-oxo-2-butenoic acids

B. Drakulić, F. Pastor, 2010 .

Antiproliferative Activity of β-Hydroxy-β-Arylalkanoic Acids

T. Stanojković, Z. Zizak, I. Juranić, 2007, International Journal of Molecular Sciences.

An LFER study of the protolytic equilibria of 4-aryl-2,4-dioxobutanoic acids in aqueous solutions

M. Zloh, B. Drakulić, V. Gordana, 2007 .

Assessment of the interacting mechanism between Candida rugosa lipases and hydroxyapatite and identification of the hydroxyapatite-binding sequence through proteomics and molecular modelling

H. Rogniaux, D. Bezbradica, B. Drakulić, 2016 .

A QSAR study of acute toxicity of N-substituted fluoroacetamides to rats.

I. Juranić, B. Drakulić, S. Petrović, 2006, Chemosphere.